Foley Represents NEA as Lead Investor in Comanche Biopharma Series B Round

Foley & Lardner LLP recently represented New Enterprise Associates, Inc. (NEA) as lead investor in Comanche Biopharma Corp’s $75 million Series B financing. Existing investors GV (Google Ventures), F-Prime Capital, Lilly Asia Ventures (LAV), and Longview Healthcare Ventures also participated in the round, along with new investor Atlas Venture. Comanche Biopharma is a maternal and […]